Fluid Overload and Mortality in Critically Ill Patients with Severe Heart Failure and Cardiogenic Shock-An Observational Cohort Study
Overview
Affiliations
Objective: Patients with heart failure (HF) and cardiogenic shock are especially prone to the negative effects of fluid overload (FO); however, fluid resuscitation in respective patients is sometimes necessary resulting in FO. We aimed to study the association of FO at ICU discharge with 30-day mortality in patients admitted to the ICU due to severe heart failure and/or cardiogenic shock.
Methods: Retrospective, single-center cohort study. Patients with admission diagnoses of severe HF and/or cardiogenic shock were eligible. The following exclusion criteria were applied: (I) patients younger than 16 years, (II) patients admitted to our intermediate care unit, and (III) patients with incomplete data to determine FO at ICU discharge. We used a cumulative weight-adjusted definition of fluid balance and defined more than 5% as FO. The data were analyzed by univariate and adjusted univariate logistic regression.
Results: We included 2,158 patients in our analysis. 185 patients (8.6%) were fluid overloaded at ICU discharge. The mean FO in the FO group was 7.2% [interquartile range (IQR) 5.8-10%]. In patients with FO at ICU discharge, 30-day mortality was 22.7% compared to 11.7% in non-FO patients ( < 0.001). In adjusted univariate logistic regression, we did not observe any association of FO at discharge with 30-day mortality [odds ratio (OR) 1.48; 95% confidence interval (CI) 0.81-2.71, = 0.2]. No association between FO and 30-day mortality was found in the subgroups with HF only or cardiogenic shock (all > 0.05). Baseline lactate (adjusted OR 1.27; 95% CI 1.13-1.42; < 0.001) and cardiac surgery at admission (adjusted OR 1.94; 95% CI 1.0-3.76; = 0.05) were the main associated factors with FO at ICU discharge.
Conclusion: In patients admitted to the ICU due to severe HF and/or cardiogenic shock, FO at ICU discharge seems not to be associated with 30-day mortality.
Pfortmueller C, Ott I, Muller M, Wilson D, Schefold J, Messmer A Sci Rep. 2024; 14(1):20897.
PMID: 39245743 PMC: 11381535. DOI: 10.1038/s41598-024-71918-x.
Khan A, Saeed H, Haque I, Iqbal A, Du D, Koratala A World J Crit Care Med. 2024; 13(2):93206.
PMID: 38855280 PMC: 11155496. DOI: 10.5492/wjccm.v13.i2.93206.
Hofer D, Ruzzante L, Waskowski J, Messmer A, Pfortmueller C Ann Intensive Care. 2024; 14(1):52.
PMID: 38587575 PMC: 11001812. DOI: 10.1186/s13613-024-01281-7.